28 October 2022
The MTPConnect team and the 18 companies in the Australian delegation are wrapping up a week of activities at the 2022 MedTech Conference in Boston.
Following the visit to JLABS @ Washington DC and the welcome networking reception with special guest Professor Ian Meredith from Boston Scientific earlier in the week, MTPConnect hosted a breakfast seminar ‘An Insider’s Guide to Commercialisation and US Market Entry’ bringing together local and international experts to share their insights with the delegation companies.
At the seminar, Frank Jaskulke, Vice President of Intelligence at Medical Alley in Minnesota explored US market entry priorities and strategies for overcoming key reimbursement and regulatory challenges. John M Collins PhD, Director Innovation Platforms, Consortia for Improving Medicine with Innovation & Technology (CIMIT) outlined the Guidance and Impact Tracking System (GAITS) platform developed at Boston University that assists companies to manage the commercialisation stages of healthcare innovations. David Hoey, President and CEO of Vaxxas, a Brisbane-based start-up that now has a US office, shared some of the realities of an Australian SME entering into the US market. Local Massachusetts experts, Mark Sullivan, Executive Director, Massachusetts Office of International Trade and Investment spoke about the Massachusetts ecosystem and opportunities for international collaboration while Rachel Robinson, Chief Operating Officer at MassMEDIC, provided an overview of the state’s vibrant medical technology sector.
As part of the delegation’s program, an Austrade briefing was also organised for the delegation involving an in-market seminar with Austrade’s Christian Carello, Director Trade-Health (USA). Stephanie Chu, First Secretary Home Affairs, Embassy of Australia explained opportunities for skilled migration to Australia to fill critical workforce shortages. Ann-Marie Nwabudike and Khatereh Calleja from AdvaMed, the world's largest medtech association representing device, diagnostics and digital technology manufacturers, spoke about AdvaMed’s initiatives to support international SMEs in the US market, including the Accel program.
During the week, members of the Australian delegation had access to exclusive personalised business coaching sessions with Medical Alley. To seal a deal, MTPConnect and the Medical Alley Association executed a Memorandum of Understanding at the Boston conference committing to working closely together to support medtech companies to grow and secure access to new markets.
The MedTech Conference brings together thousands of the world’s top medtech executives and innovators for three days of programs, networking and business development opportunities. As the event comes to an end, we want to congratulate the members of the Australian delegation for participating in MTPConnect’s US mission and wish them well as they continue to develop their innovations towards success.
Australia’s medtech delegation - Cortical Dynamics, CROW Clinical, CSIRO, Customa, Datarwe, Design + Industry, Ferronova, Hydrix, IDE Group, iiShield, Jay-Nik, Mobius Medical, Optiscan, Proteomics International, ResusRight, Singular Health, Virtetic and WearOptimo - has shown the world that we are open for business!